metformin has been researched along with Gram-Positive Bacterial Infections in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Gram-Positive Bacterial Infections: Infections caused by bacteria that retain the crystal violet stain (positive) when treated by the gram-staining method.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, X | 1 |
| Fan, W | 1 |
| Fan, B | 1 |
1 other study available for metformin and Gram-Positive Bacterial Infections
| Article | Year |
|---|---|
Synergistic effects of silver ions and metformin against enterococcus faecalis under high-glucose conditions in vitro.
Topics: 3T3 Cells; Animals; Anti-Bacterial Agents; Drug Synergism; Enterococcus faecalis; Glucose; Gram-Posi | 2021 |